Evidence map›Paper›PMID 33827678›Full record

ArticleClinical epigenetics2021

Parthenogenetic mosaicism: generation via second polar body retention and unmasking of a likely causative PER2 variant for hypersomnia.

Yohei Masunaga, Masayo Kagami, Fumiko Kato, Takeshi Usui, Takako Yonemoto, Kazuo Mishima, Maki Fukami, Kazushi Aoto, Hirotomo Saitsu, Tsutomu Ogata

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical epigenetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Yohei MasunagaDepartment of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Masayo KagamiDepartment of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.
Fumiko KatoDepartment of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Takeshi UsuiDepartment of Medical Genetics, Shizuoka General Hospital, Shizuoka, Japan.
Takako YonemotoDepartment of Diabetes and Endocrinology, Shizuoka General Hospital, Shizuoka, Japan.
Kazuo MishimaDepartment of Psychiatry Section of Neuro and Locomoter Science, Akita University School of Medicine, Akita, Japan.
Maki FukamiDepartment of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.
Kazushi AotoDepartment of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Hirotomo SaitsuDepartment of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Tsutomu OgataDepartment of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan. tomogata@hama-med.ac.jp.ORCID 0000-0001-7178-9991
Hamamatsu University School of Medicine · JPNational Center For Child Health and Development · JPShizuoka General Hospital · JPAkita University · JPHamamatsu University · JP

Funding

Japan Agency for Medical Research and Development JP20ek0109301Japan Agency for Medical Research and Development JP20ek0109373Japan Agency for Medical Research and Development JP20ek0109464Japan Society for the Promotion of Science 17H06428
6 · The paper itself

Abstract

backgroundParthenogenetic mosaicism is an extremely rare condition identified only in five subjects to date. The previous studies indicate that this condition is mediated by parthenogenetic activation and is free from a specific phenotype ascribed to unmaking of a maternally inherited recessive variant in the parthenogenetic cell lineage.

resultsWe examined a 28-year-old Japanese 46,XX female with Silver-Russell syndrome and idiopathic hypersomnia. The results revealed (1) predominance of maternally derived alleles for all the differentially methylated regions examined; (2) no disease-related copy-number variant; (3) two types of regions for all chromosomes, i.e., four BAF (B-allele frequency) band regions with single major microsatellite peaks of maternal origin and single minor microsatellite peaks of non-maternal (paternal) origin, and six BAF band regions with single major microsatellite peaks of maternal origin and two minor microsatellite peaks of maternal and non-maternal (paternal) origin; (4) an unmasked extremely rare PER2 variant (c.1403G>A:p.(Arg468Gln)) with high predicted pathogenicity; (5) mildly affected local structure with altered hydrogen bonds of the p.Arg468Gln-PER2 protein; and (6) nucleus-dominant subcellular distribution of the p.Arg468Gln-PER2 protein.

conclusionsThe above findings imply that the second polar body retention occurred around fertilization, resulting in the generation of the parthenogenetic cell lineage by endoreplication of a female pronucleus and the normal cell lineage by fusion of male and female pronuclei, and that the homozygous PER2 variant in the parthenogenetic cells is the likely causative factor for idiopathic hypersomnia.

Indexed as

Genetic Predisposition to DiseaseMosaicismPolar BodiesAdultAsian PeopleDisorders of Excessive SomnolenceFemaleGenetic VariationGenotypeHumansParthenogenesisPeriod Circadian ProteinsPeriod Circadian ProteinsIdiopathic hypersomniaParthenogenesisPER2Second polar body retentionUnmasked variant

Identifiers

PMID33827678
PMCPMC8028705
OpenAlexW3148383531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.